0001371285-24-000128.txt : 20240515 0001371285-24-000128.hdr.sgml : 20240515 20240515192719 ACCESSION NUMBER: 0001371285-24-000128 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240507 FILED AS OF DATE: 20240515 DATE AS OF CHANGE: 20240515 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: RAWLINGS DARRYL CENTRAL INDEX KEY: 0001611679 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-36537 FILM NUMBER: 24953186 MAIL ADDRESS: STREET 1: 6100 4TH AVENUE SOUTH STREET 2: SUITE 200 CITY: SEATTLE STATE: WA ZIP: 98108 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TRUPANION, INC. CENTRAL INDEX KEY: 0001371285 STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324] ORGANIZATION NAME: 02 Finance IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6100 4TH AVENUE SOUTH STREET 2: SUITE 400 CITY: SEATTLE STATE: WA ZIP: 98108 BUSINESS PHONE: 888-733-2685 MAIL ADDRESS: STREET 1: 6100 4TH AVENUE SOUTH STREET 2: SUITE 400 CITY: SEATTLE STATE: WA ZIP: 98108 FORMER COMPANY: FORMER CONFORMED NAME: TRUPANION INC. DATE OF NAME CHANGE: 20131114 FORMER COMPANY: FORMER CONFORMED NAME: VETINSURANCE INTERNATIONAL INC DATE OF NAME CHANGE: 20060802 4/A 1 wk-form4a_1715815625.xml FORM 4/A X0508 4/A 2024-05-07 2024-05-09 0 0001371285 TRUPANION, INC. TRUP 0001611679 RAWLINGS DARRYL C/O TRUPANION, INC. 6100 4TH AVENUE SOUTH, SUITE 200 SEATTLE WA 98108 1 1 0 0 Chief Executive Officer 0 Common Stock 2024-05-07 4 P 0 20700 24.1383 A 614842 D On May 9, 2024, the reporting person filed a Form 4 to report a purchase of 20,700 shares but, footnote 1 inadvertently used the word sold instead of purchased in the second and third sentences. The only change reported by this amendment is to clarify in the footnote that the reported transaction was a purchase. The proper footnote reads as follows: The reported price in Column 4, is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $23.46 to $24.16 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1). /s/ Lauren Welsh as attorney-in-fact for Darryl Rawlings 2024-05-15